December 23, 2020 — The U.S. Food and Drug Administration December 18 issued an emergency use authorization (EUA) for a ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor
December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for ...
December 14, 2020
November 17, 2020 — A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary ...
November 17, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to ...
November 16, 2020
November 16, 2020 — Among patients who stopped taking their cholesterol-lowering statin medication due to side effects ...
November 16, 2020
November 16, 2020 — Novartis announced results from two pooled post-hoc analyses of Phase III ORION-9, -10 and -11 ...
November 16, 2020
News | Coronavirus (COVID-19) | Dave Fornell, Editor
November 9, 2020 — A National Institutes of Health (NIH) clinical trial evaluating the safety and effectiveness of hydro ...
November 09, 2020
Short-term Hydroxychloroquine Use in COVID-19 Patients Does Not Cause Lethal Arrhythmias if Screened
September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients ...
September 25, 2020
September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health resear ...
September 24, 2020
September 17, 2020 — Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of C ...
September 17, 2020
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...
September 11, 2020
Matthew Budoff, M.D., director of cardiovascular CT at The Lundquist Institute, and professor of medicine at the David ...
September 10, 2020
September 10, 2020 - Icosapent ethyl (Vascepa) demonstrated significant, 17 percent regression of low attenuation plaque ...
September 10, 2020
September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...
September 08, 2020
July 28, 2020 — AstraZeneca's heart failure medication dapagliflozin (Farxiga) significantly reduced the worsening of ...
July 28, 2020